Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Yamanouchi characterizes new vasopressin antagonist, YM-087

April 7, 1997

FDA clears Faulding's generic captopril

April 7, 1997

Perindopril accelerates endothelial regrowth in animal model

April 7, 1997

Targeted Genetics' AAV vector useful for in vivo cardiovascular gene therapy

April 4, 1997

Mitsubishi Chemical isolates antihypertensive compound from natural source

April 4, 1997

Digital Gene Technologies and Recordati collaborate on atherosclerosis research

April 4, 1997

Roberts licenses cardiovascular drug from Pfizer

April 3, 1997

Cardioprotective and cerebroprotective agents from Pierre Fabre

April 3, 1997

More endothelin antagonists from SKB

April 3, 1997

NeoRx licenses Biostent to Schwarz

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...